Pfizer-BioNTech and Oxford AstraZeneca COVID-19 vaccine effectiveness and immune response amongst individuals in clinical risk groups
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference35 articles.
1. Risk factors for SARS-CoV-2 among patients in the oxford royal college of general practitioners research and surveillance Centre primary care network: a cross-sectional study;de Lusignan;Lancet Infect Dis,2020
2. Factors associated with COVID-19-related death using OpenSAFELY;Williamson;Nature,2020
3. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study;Clift;BMJ,2020
4. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020
5. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK;Voysey;Lancet,2020
Cited by 76 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Protocol for an e-Delphi study to achieve consensus on a definitive adult immunosuppressed phenotype (Preprint);2024-01-11
2. Reported side-effects following Oxford/AstraZeneca COVID-19 vaccine in the north-west province, Iran: A cross-sectional study;PLOS ONE;2024-01-05
3. Development and validation of a modified version of the Cambridge Multimorbidity Score (CMMS) for use in the English nationwide General Practice Extraction Service Data for Pandemic Planning and Research (GDPPR) dataset (Preprint);2024-01-03
4. Case Study of Autopsy Findings in a Population of Post-COVID-19 Vaccination in Thailand;American Journal of Forensic Medicine & Pathology;2023-12-21
5. Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study;Drug Safety;2023-12-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3